Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 03/31/2020

Month EndAs of 03/31/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) -0.85 1.83 -1.77 13.60 10.48
Fund with Sales Charge (%) (POP) -0.85 1.83 -1.77 13.60 10.48
NASDAQ Biotechnology Index (%) -3.42 3.39 -1.17 13.82 11.02
S&P 500 Index (%) -6.98 5.10 6.72 10.53 6.69
Quarter EndAs of 03/31/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) -0.85 1.83 -1.77 13.60 10.48
Fund with Sales Charge (%) (POP) -0.85 1.83 -1.77 13.60 10.48
NASDAQ Biotechnology Index (%) -3.42 3.39 -1.17 13.82 11.02
S&P 500 Index (%) -6.98 5.10 6.72 10.53 6.69

After-Tax Average Annual Total Returns [further-information] As of 03/31/2020

Month EndAs of 03/31/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -2.81 0.57 -3.20 12.17
Fund without Sales Charge (%) (NAV) After Shares Sold 1.27 1.38 -1.50 11.11
Fund with Sales Charge (%) (POP) Before Shares Sold -2.81 0.57 -3.20 12.17
Fund with Sales Charge (%) (POP) After Shares Sold 1.27 1.38 -1.50 11.11
Quarter EndAs of 03/31/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -2.81 0.57 -3.20 12.17
Fund without Sales Charge (%) (NAV) After Shares Sold 1.27 1.38 -1.50 11.11
Fund with Sales Charge (%) (POP) Before Shares Sold -2.81 0.57 -3.20 12.17
Fund with Sales Charge (%) (POP) After Shares Sold 1.27 1.38 -1.50 11.11

Calendar Year Returns

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund without Sales Charge (%) (NAV) 35.19 -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65 17.64
Fund with Sales Charge (%) (POP) 35.19 -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65 17.64
NASDAQ Biotechnology Index (%) 24.41 -9.32 21.06 -21.68 11.42 34.32 65.97 32.29 12.08 15.25
S&P 500 Index (%) 31.49 -4.38 21.83 11.96 1.38 13.69 32.39 16.00 2.11 15.06

Cumulative Total Returns [further-information] As of 03/31/2020

Month EndAs of 03/31/2020 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -12.38 -12.38 -0.85 5.59 -8.56 258.07 845.63
Fund with Sales Charge (%) (POP) -12.38 -12.38 -0.85 5.59 -8.56 258.07 845.63
NASDAQ Biotechnology Index (%) -10.41 -10.41 -3.42 10.52 -5.70 265.12 954.58
S&P 500 Index (%) -19.60 -19.60 -6.98 16.11 38.47 172.10 330.05
Quarter EndAs of 03/31/2020 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -12.38 -12.38 -0.85 5.59 -8.56 258.07 845.63
Fund with Sales Charge (%) (POP) -12.38 -12.38 -0.85 5.59 -8.56 258.07 845.63
NASDAQ Biotechnology Index (%) -10.41 -10.41 -3.42 10.52 -5.70 265.12 954.58
S&P 500 Index (%) -19.60 -19.60 -6.98 16.11 38.47 172.10 330.05

MODERN PORTFOLIO THEORY (MPT) STATISTICSAs of 03/31/2020 (updated monthly)

3 YR 5 YR 10 YR
Standard Deviation (Fund) 22.79 25.07 23.05
Standard Deviation (NASDAQ Biotechnology Index) 20.76 23.27 21.21
Beta 1.05 1.05 1.05
Sharpe Ratio 0.01 -0.11 0.56
Information Ratio -0.24 -0.10 -0.04
Tracking Error 6.40 6.00 6.11

ADDITIONAL RISK STATISTICSAs of 03/31/2020 (updated monthly)

3 YR 5 YR 10 YR
Beta Bull 1.00 0.95 1.03
Beta Bear 0.91 0.99 1.02
Bull Bear Capture Ratio 1.00 1.04 1.01
% of Positive Months 52.78 53.33 60.00
Gains/Losses 1.15 1.04 1.63
Maximum Drawdown
23.49 37.55 37.55

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 0.79%
Net Expense Ratio [further-information] 0.77%
Max Initial Sales Charge 0.00%
CDSC

Volatility Measures [further-information] As of 03/31/2020 Updated Monthly, based on a 3-year period

Beta 1.05
Sharpe Ratio 0.01
Standard Deviation 22.79

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index